Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
EPA CPDat observed this chemical in 161 composition records across product categories including Construction and building materials, Laboratory supplies, Food and drug.
Concern score
The concern value is driven by the published classifications and regulatory status below — not by a single signal.
Concern score 5/100 (low) · emerging confidence.
Prevalence of ANHYDROUS DEXTROSE in our catalog (epa_cpdat).
Products
161
Brands
6
Typical roles
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
Fragrance avoidance
Not a strong fit for fragrance avoidance because it carries Fragrance.
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
US
EPA
EPA CPDat observed this chemical in 161 composition records across product categories including Construction and building materials, Laboratory supplies, Food and drug. EPA CPDat classifies this chemical for functional uses including Humectant, Flavouring and nutrient, Pharmaceutical.
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION; Maximum daily exposure: 300 mg
US
FDA
The ingredient itself is a fragrance-linked signal, so it is better treated as an avoid case when fragrance exposure is the main concern.
The published evidence profile currently shaping this ingredient record.
Route: INTRAMUSCULAR; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 3.9 %w/v
US
FDA
Route: INTRASPINAL; Dosage form: INJECTION; Potency: 8.25 %w/v
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION; Maximum daily exposure: 36000 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 3.9 %w/v
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Potency: 5 %w/v
US
FDA
Route: NASAL; Dosage form: SPRAY; Maximum daily exposure: 36 mg
US
FDA
Route: NASAL; Dosage form: SPRAY, METERED; Maximum daily exposure: 40 mg
US
FDA
Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION; Maximum daily exposure: 16878 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 17406 mg
US
FDA
Route: ORAL; Dosage form: TABLET, CHEWABLE; Maximum daily exposure: 1592 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 30 mg
US
FDA
Route: SUBCUTANEOUS; Dosage form: INJECTION; Potency: 7.5 %w/v
US
FDA
FDA NDC lists this ingredient in 8 active drug products and 8 total products.
US
FDA
openFDA substance registry classifies this ingredient as chemical.
US
FDA
openFDA substance registry classifies this ingredient as concept.